|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen KD, Huang KT, Lin CC, Weng WT, Hsu
LW, Goto S, Nakano T, Lai CY, Kung CP, Chiu KW, et al: MicroRNA-27b
enhances the hepatic regenerative properties of adipose-derived
mesenchymal stem cells. Mol Ther Nucleic Acids. 5:e2852016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karlsen TA, de Souza GA, Odegaard B,
Engebretsen L and Brinchmann JE: microRNA-140 inhibits inflammation
and stimulates chondrogenesis in a model of interleukin 1β-induced
Osteoarthritis. Mol Ther Nucleic Acids. 5:e3732016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and
Buchanan P: Lung cancer: Biology and treatment options. Biochim.
Biophys Acta. 1856:189–210. 2015.
|
|
5
|
Huang K, Dong X, Sui C, Hu D, Xiong T,
Liao S and Zhang H: MiR-223 suppresses endometrial carcinoma cells
proliferation by targeting IGF-1R. Am J Transl Res. 6:841–849.
2014.PubMed/NCBI
|
|
6
|
Huang X, Huang M, Kong L and Li Y: miR-372
suppresses tumour proliferation and invasion by targeting IGF2BP1
in renal cell carcinoma. Cell Prolif. 48:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
8
|
Kim G, An HJ, Lee MJ, Song JY, Jeong JY,
Lee JH and Jeong HC: Hsa-miR-1246 and hsa-miR-1290 are associated
with stemness and invasiveness of non-small cell lung cancer. Lung
Cancer. 91:15–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Z, He J, Gao P, Niu Y, Zhang J, Wang
L, Liu M, Wei X, Liu C, Zhang C, et al: miR-769-5p suppressed cell
proliferation, migration and invasion by targeting TGFBR1 in
non-small cell lung carcinoma. Oncotarget. 8:113558–113570. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li G, Wu F, Yang H, Deng X and Yuan Y:
MiR-9-5p promotes cell growth and metastasis in non-small cell lung
cancer through the repression of TGFBR2. Biomed Pharmacother.
96:1170–1178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang M, Meng B and Liu Y, Yu J, Chen Q and
Liu Y: MiR-124 inhibits growth and enhances radiation-induced
apoptosis in non-small cell lung cancer by inhibiting STAT3. Cell
Physiol Biochem. 44:2017–2028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu G, Fu D, Jia C, Chai L, Han Y, Liu J,
Wu T, Xie R, Chang Z, Yang H, et al: Reduced miR-105-1 levels are
associated with poor survival of patients with non-small cell lung
cancer. Oncol Lett. 14:7842–7848. 2017.PubMed/NCBI
|
|
13
|
Zhou Q, Huang SX, Zhang F, Li SJ, Liu C,
Xi YY, Wang L, Wang X, He QQ, Sun CC and Li DJ: MicroRNAs: A novel
potential biomarker for diagnosis and therapy in patients with
non-small cell lung cancer. Cell Prolif. 50:2017. View Article : Google Scholar :
|
|
14
|
Hongdan L and Feng L: miR-3120-5p promotes
colon cancer stem cell stemness and invasiveness through targeting
Axin2. Biochem Biophys Res Commun. 496:302–308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai Y, Ruan J, Yao X, Zhao L and Wang B:
MicroRNA-187 modulates epithelial-mesenchymal transition by
targeting PTRF in non-small cell lung cancer. Oncol Rep.
37:2787–2794. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng R, Lu C, Zhang G, Zhang G and Zhao
G: Overexpression of miR-203 increases the sensitivity of NSCLC
A549/H460 cell lines to cisplatin by targeting Dickkopf-1. Oncol
Rep. 37:2129–2136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu G, Shao G, Pan Q, Sun L, Zheng D, Li M,
Li N, Shi H and Ni Y: MicroRNA-9 regulates non-small cell lung
cancer cell invasion and migration by targeting eukaryotic
translation initiation factor 5A2. Am J Transl Res. 9:478–488.
2017.PubMed/NCBI
|
|
19
|
Chen S, Jiang S, Hu F, Xu Y, Wang T and
Mei Q: Foxk2 inhibits non-small cell lung cancer
epithelial-mesenchymal transition and proliferation through the
repression of different key target genes. Oncol Rep. 37:2335–2347.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhijun Z and Jingkang H: MicroRNA-520e
suppresses non-small-cell lung cancer cell growth by targeting
Zbtb7a-mediated Wnt signaling pathway. Biochem. Biophys Res Commun.
486:49–56. 2017. View Article : Google Scholar
|
|
21
|
Shi L, Xu Z, Wu G, Chen X, Huang Y, Wang
Y, Jiang W and Ke B: Up-regulation of miR-146a increases the
sensitivity of non-small cell lung cancer to DDP by downregulating
cyclin J. BMC Cancer. 17:1382017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi ZM, Wang L, Shen H, Jiang CF, Ge X, Li
DM, Wen YY, Sun HR, Pan MH, Li W, et al: Downregulation of miR-218
contributes to epithelial-mesenchymal transition and tumor
metastasis in lung cancer by targeting Slug/ZEB2 signaling.
Oncogene. 36:2577–2588. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye B, Liu B, Hao L, Zhu X, Yang L, Wang S,
Xia P, Du Y, Meng S, Huang G, et al: Klf4 glutamylation is required
for cell reprogramming and early embryonic development in mice. Nat
Commun. 9:12612018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li S, Huang L, Gu J, Wu J, Ou W, Feng J,
Liu B, Xu X and Zhou Y: Restoration of KLF4 Inhibits Invasion and
Metastases of Lung Adenocarcinoma through Suppressing MMP2. J
Cancer. 8:3480–3489. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu LP, Wu J, Shang A, Yang M, Li LL, Yu J,
Xu LR, Wang CB, Wang WW, Zhu JJ and Lu WY: miR-124 inhibits
progression of hepatocarcinoma by targeting KLF4 and promises a
novel diagnostic marker. Artif Cells Nanomed Biotechnol. Dec
18–2017.(Epub ahead of print). View Article : Google Scholar
|
|
26
|
Hu W, Hofstetter WL, Li H, Zhou Y, He Y,
Pataer A, Wang L, Xie K, Swisher SG and Fang B: Putative
tumor-suppressive function of Kruppel-like factor 4 in primary lung
carcinoma. Clin Cancer Res. 15:5688–5695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Y, Hofstetter WL, He Y, Hu W, Pataer
A, Wang L, Wang J, Zhou Y, Yu L, Fang B and Swisher SG: KLF4
inhibition of lung cancer cell invasion by suppression of SPARC
expression. Cancer Biol Ther. 9:507–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fadous-Khalife MC, Aloulou N, Jalbout M,
Hadchity J, Aftimos G, Paris F and Hadchity E: Kruppel-like factor
4: A new potential biomarker of lung cancer. Mol Clin Oncol.
5:35–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
